Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bayzed Health GroupHKSE:02609 -1.81%12 Return-on-Tangible-Equity is 4.64% as of Dec. 2025. GuruFocus rates HKSE:02609 with a GF Score™ of 12/100. The stock has 2 warning signs investors should review. Among 577 Healthcare Providers & Services companies, Bayzed Health Group ranks worse than 78.34% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Bayzed Health Group's annualized net income for the quarter that ended in Dec. 2025 was HK$32 Mil. Bayzed Health Group's average shareholder tangible equity for the quarter that ended in Dec. 2025 was HK$698 Mil. Therefore, Bayzed Health Group's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 4.64%.
The historical rank and industry rank for Bayzed Health Group's Return-on-Tangible-Equity or its related term are showing as below:
HKSE:02609'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -30.27 Med: -16.1 Max: -2.67
Current: -2.67
During the past 5 years, Bayzed Health Group's highest Return-on-Tangible-Equity was -2.67%. The lowest was -30.27%. And the median was -16.10%.
HKSE:02609's Return-on-Tangible-Equity is ranked worse than 78.34% of 577
companies
in the Healthcare Providers & Services industry
Industry Median: 10.65
vs HKSE:02609: -2.67
Bayzed Health Group (HKSE:02609) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Bayzed Health Group Return-on-Tangible-Equity Related Terms
Bayzed Health Group Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Bayzed Health Group's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bayzed Health Group Return-on-Tangible-Equity Chart
HKSE:02609 vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Bayzed Health Group's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bayzed Health Group Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Bayzed Health Group's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Bayzed Health Group's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 4.64% mean?
Bayzed Health Group (HKSE:02609) has a Return-on-Tangible-Equity of 4.64% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Bayzed Health Group and its competitors. According to the industry distribution chart, Bayzed Health Group ranks #452 out of 577 companies in the Healthcare Providers & Services industry, placing it in the top 78.3%.
Is Bayzed Health Group's Return-on-Tangible-Equity too high?
Bayzed Health Group's current Return-on-Tangible-Equity is 4.64%. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.65. Bayzed Health Group's value of 4.64% is 56.4% below this industry median. Based on the distribution chart, Bayzed Health Group ranks #452 out of 577 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Bayzed Health Group has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bayzed Health Group's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Bayzed Health Group ranks #452 out of 577 companies for Return-on-Tangible-Equity. This places Bayzed Health Group in the lower half of its industry. The industry median Return-on-Tangible-Equity is 10.65. Bayzed Health Group's value of 4.64% is 56.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.65, based on 577 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bayzed Health Group's current Return-on-Tangible-Equity of 4.64% is 56.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Bayzed Health Group and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bayzed Health Group's current Return-on-Tangible-Equity is 4.64%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bayzed Health Group stock overvalued right now?
Bayzed Health Group (HKSE:02609) has a current Return-on-Tangible-Equity of 4.64%. The current Return-on-Tangible-Equity is 4.64% and 56.4% below the Healthcare Providers & Services industry median of 10.65. Bayzed Health Group's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Bayzed Health Group (HKSE:02609), the current Return-on-Tangible-Equity is 4.64% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bayzed Health Group Inc is an oncology healthcare group that principally engages in the investment in, and provision of, medical and healthcare related services in the PRC. It operates and manages a network of eight hospitals in Beijing, Tianjin, Shanxi Province, Anhui Province, and Henan Province, with a strategic focus on the provision of full-cycle oncology healthcare services through its direct ownership of the equity interest in six private for-profit hospitals and management over two private not-for-profit hospitals.
12GF Score
Get the complete analysis for HKSE:02609
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02609 has been successfully added to your 
